| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Amicus Therapeutics, Inc. (FOLD) has 6 insiders with recent SEC Form 4 filings, including 1 buy and 11 sells. FOLD is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.02M | $14.80M | - | |
| Other | 464.6K | $6.73M | - | |
| Other | 409.3K | $5.93M | - | |
| Other | 221.8K | $3.21M | - | |
| CFO | 143.6K | $2.08M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 10, 2020 | Barth Jay | Chief Medical Officer | Sale+OE | 73,290 | $15.81 | $1,158,927.34 | -18.3% | |
| Jul 8, 2020 | Campbell Bradley L66 | Chief Operating Officer | Sale+OE | 2,500 | $16.01 | $40,025.00 | -0.7% | |
| Jul 8, 2020 | Barth Jay | Chief Medical Officer | Sale+OE | 243,098 | $15.91 | $3,866,518.50 | -42.7% | |
| Jul 2, 2020 | Prout Samantha68 | Principal Accounting Officer | Sale+OE | 198 | $15.80 | $3,128.40 | -1.1% | |
| Jul 1, 2020 | Campbell Bradley L66 | Chief Operating Officer | Sale+OE | 12,500 | $15.47 | $193,383.75 | -3.6% | |
| Jul 1, 2020 | Crowley John F67 | Chairman &CEO | Sale+OE | 39,655 | $15.48 | $613,859.40 | -4.3% | |
| Jul 1, 2020 | Quimi Daphne58 | Chief Financial Officer | Sale+OE | 6,872 | $15.47 | $106,325.65 | -3.2% | |
| Jul 1, 2020 | Whitman Burke W50 | Director | Buy | 1,500 | $15.20 | $22,800.00 | +5.1% | |
| Jun 29, 2020 | Barth Jay | Chief Medical Officer | Sale+OE | 30,000 | $15.51 | $465,195.00 | -15.5% | |
| Jun 19, 2020 | Prout Samantha68 | Principal Accounting Officer | Sale+OE | 3,366 | $15.00 | $50,490.00 | -16.4% |